In addition, there were more metastatic lung nodes in the BCPAP/NC shRNA groups than that in the BCPAP/NC shRNA groups (Figure 4(e)), indicating that targeting eIF5A2 inhibits tumor metastasis in vivo. This evidence concerns the gene EIF5A2 and neoplasm.